HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Dilated Cardiomyopathy

Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM) is a serious heart condition characterized by the enlargement of the heart chambers, specifically the left ventricle. This disorder weakens the heart muscle, impairing its ability to pump blood efficiently. As a result, the heart becomes dilated and weakened, leading to a decrease in the overall pumping function. DCM can be caused by a variety of factors, including genetic predisposition, viral infections, certain medications, and exposure to toxins. The symptoms of DCM often include fatigue, shortness of breath, swelling in the legs, and an irregular heartbeat. Timely identification plays a pivotal role in effectively managing the condition and averting potential complications.. Treatment options may include medications, lifestyle changes, and in severe cases, heart transplant. Regular medical monitoring and adherence to a heart-healthy lifestyle are essential for individuals living with Dilated Cardiomyopathy.

Committee Members
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States

Submit your abstract Today

Watsapp